Enzo Biochem Debt 2025

Enzo Biochem Aktienanalyse

What does Enzo Biochem do?

Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Enzo Biochem's Debt Structure

Enzo Biochem's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Enzo Biochem's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Enzo Biochem’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Enzo Biochem’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Enzo Biochem stock

What is the debt of Enzo Biochem this year?

Enzo Biochem has a debt level of -52.11 USD this year.

What was the debt of Enzo Biochem compared to the previous year?

The debt of Enzo Biochem has increased by -34.47% compared to the previous year dropped.

What are the consequences of high debt for investors in Enzo Biochem?

High debt can pose a risk for investors of Enzo Biochem, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Enzo Biochem?

Low debt means that Enzo Biochem has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Enzo Biochem affect the company?

An increase in debt of Enzo Biochem can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Enzo Biochem affect the company?

A reduction in debt of Enzo Biochem can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Enzo Biochem?

Some factors that can influence the debt of Enzo Biochem include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Enzo Biochem so important for investors?

The debts of Enzo Biochem are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Enzo Biochem take to change the debt?

To change the debt, Enzo Biochem can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Enzo Biochem pay?

Over the past 12 months, Enzo Biochem paid a dividend of 0.1 USD . This corresponds to a dividend yield of about 31.25 %. For the coming 12 months, Enzo Biochem is expected to pay a dividend of 0.1 USD.

What is the dividend yield of Enzo Biochem?

The current dividend yield of Enzo Biochem is 31.25 %.

When does Enzo Biochem pay dividends?

Enzo Biochem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzo Biochem?

Enzo Biochem paid dividends every year for the past 1 years.

What is the dividend of Enzo Biochem?

For the upcoming 12 months, dividends amounting to 0.1 USD are expected. This corresponds to a dividend yield of 31.25 %.

In which sector is Enzo Biochem located?

Enzo Biochem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzo Biochem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzo Biochem from 12/2/2024 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Enzo Biochem pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Enzo Biochem in the year 2024?

In the year 2024, Enzo Biochem distributed 0 USD as dividends.

In which currency does Enzo Biochem pay out the dividend?

The dividends of Enzo Biochem are distributed in USD.